Developer docs
API playgroundTry for free, no card

Search company profiles

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü

Full company profile

uuid004pphh

Namestring
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
Legal namestring
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
Websiteurl
kanver.org
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the General Directorate of Blood Services of the Turkish Red Crescent (Türkiye Kızılay Derneği), a public-benefit humanitarian association established as a separate directorate in 1983 with blood service roots dating to 1921. It is the legally designated national blood supply authority of Turkey under Law No. 5624, operating 18 Regional Blood Centers, 68 Blood Donation Centers, and approximately 300 daily mobile collection points covering all 81 provinces. In 2025, the organization collected 3,041,278 units of blood, the highest annual figure in its history, with 1,246,400 additional units in the first five months of 2026. The technical backbone is a blood-banking automation system implemented in 2006, an integrated quality management system certified to ISO 9001:2015 and ISO 10002:2018, and nucleic acid amplification testing (NAT) added October 30, 2014 for HIV, Hepatitis B, Hepatitis C, and Syphilis screening.

Core service lines include voluntary whole-blood donation, apheresis (platelet) donation, plasma donation, and stem cell coordination through TÜRKÖK, a national registry jointly operated with the Ministry of Health since November 7, 2013, which holds 1,231,392 active donor candidates and has completed 8,500 stem cell collections. Supporting assets include the iOS/Android Türk Kızılay Mobil Kan Bağışı application, the kanver.org appointment platform, university (Hedef 25), school (Okulumda Kanpanya Var), youth (Genç Kızılay Kan Elçileri), and mukhtar-led neighborhood (Mahallenin Gücü) donor acquisition programs, the Blood Donation League sports-fan campaign, and a thalassemia/sickle-cell patient-donor matching project (BİS).

Blood and blood components are provided free of charge to hospitals and patients as a public service; no revenue is generated from blood product distribution. Operations are funded through government support, donations, and the parent Türk Kızılay's humanitarian funding base, with no external investors or venture capital involved. Forward strategy centers on the Protürk Plasma Drug Facility, a joint venture with South Korea's SK Plasma in Çubuk, Ankara (groundbreaking June 2026), intended to manufacture albumin, immunoglobulin, and clotting factors domestically and reduce an estimated €450 million in annual plasma-derived medicine imports.

Short descriptiontext

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the Turkish Red Crescent's national blood services directorate, operating 18 regional blood centers and 68 donation centers across all 81 provinces of Turkey to collect, test, and distribute blood, apheresis, plasma, and stem cell donations free of charge to hospitals and patients under Law No. 5624.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAnkara, Türkiye
HQ citystring
Ankara
HQ countrystring
Türkiye
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
blood banking services, voluntary blood donation, stem cell donation, apheresis services, plasma collection
Industry4 codes
1Blood, Organ & Tissue Donation Organizations
CodeBPAGACAJPrimaryYes
2Blood Bank, Transfusion Medicine & Immunohematology
CodeHLAHAAAHPrimaryNo
3Plasma Collection & Donor Services (Plasmapheresis Centers)
CodeHLAIAHAHPrimaryNo
4Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors)
CodeHLAAAAAIPrimaryNo
NAICS code1 code
  • Blood and Organ Banks621991
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Blood Banking Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Blood and Blood Products (Public Service — No Revenue)
TypeOne Time License
Description

Türk Kızılay provides blood and blood components free of charge to patients. No fee is charged to patients or their relatives for blood component therapy. This is a public service mandate under Law No. 5624 and does not generate revenue.

kanver.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1TÜRKÖK
Description

Türkiye Kök Hücre Koordinasyon Merkezi – Turkey Stem Cell Coordination Center. A joint initiative with the Ministry of Health for hematopoietic stem cell donor recruitment, HLA registry, and bone marrow bank database.

kanver.org
+6 more records
Core offering1 text field

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the national blood services authority of Turkey, operating 18 Regional Blood Centers and 68 Blood Donation Centers to collect, test, process, store, and distribute whole blood, erythrocytes, platelets, and plasma free of charge to hospitals. It also coordinates the national hematopoietic stem cell donor registry (TÜRKÖK) with over 1.2 million registered donors for bone marrow transplantation, and is establishing domestic plasma-derived pharmaceutical production through the Protürk facility.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 3,041,278 units of blood collected in 2025 — highest annual figure in the organization's history
+7 more records
Product overview1 text field

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü operates as Turkey's national blood services authority, managing a comprehensive blood supply system through its network of 18 Regional Blood Centers and 68 Blood Collection Facilities. The organization's product portfolio centers on four core service areas: blood donation (including appointments at collection points and mobile units), apheresis services for platelet collection, stem cell donation coordination through the TÜRKÖK national registry, and plasma services. Supporting these core operations are digital platforms including the online blood donation appointment system, the mobile application for iOS/Android, the Blood Donation League gamification initiative, and targeted programs like the 'Biz İyilik Severiz' thalassemia patient-donor matching project. The organization also coordinates international cooperation through its role in the World Bone Marrow Registry and manages educational initiatives including the Hedef 25 university awareness program.

Product and service5 records
1Kan Bağışı (Whole Blood Donation Service)
CategoryBlood Collection and Distribution
Description

Voluntary whole blood collection from donors at regional centers, donation points, and mobile collection teams; blood is tested (including NAT screening for HIV, Hepatitis B, Hepatitis C, Syphilis), processed into erythrocyte, platelet, and plasma components, and supplied free of charge to hospitals and transfusion centers for patient treatment.

2Aferez Bağışı (Apheresis Donation Service)
CategoryBlood Component Collection
Description

Apheresis procedure that separates and collects specific blood components (primarily platelets) from donors while returning other components to the donor. Performed at regional blood centers to support patients requiring targeted platelet transfusions.

3Plazma Bağışı (Plasma Donation Service)
CategoryPlasma Collection and Pharmaceutical Production
Description

Plasma collection from donors for domestic manufacturing of plasma-derived pharmaceuticals (Albumin, Immunoglobulin, clotting factors) through the Protürk Plasma Drug Facility, reducing Turkey's annual import dependency by approximately €450 million.

4TÜRKÖK Stem Cell Donor Coordination Service
CategoryStem Cell Coordination
Description

National hematopoietic stem cell donor registry and matching service operated jointly with the Ministry of Health; recruits volunteer donors, performs HLA tissue typing, maintains a database of over 1.2 million donor candidates, and has completed 36,905 patient-donor matchings and 8,500 stem cell collections since inception.

5Türk Kızılay Mobil Kan Bağışı Uygulaması (Mobile Blood Donation App)
CategoryDigital Donor Engagement
Description

Mobile application available on iOS and Android for donor registration, appointment booking at blood donation points, blood type card access, and SMS notifications when donated blood is used by a patient.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-15
Description

Türk Kızılay and South Korean SK Plasma are collaborating to build the Protürk Plasma Drug Facility in Çubuk, Ankara. The facility will produce plasma-derived medicines (Albumin, Immunoglobulin, Clotting Factors) domestically, reducing Turkey's import dependency by approximately €450 million annually and creating ~300 jobs.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-11-07
Description

TÜRKÖK (Türkiye Kök Hücre Koordinasyon Merkezi) is a joint initiative between Türk Kızılay and the Ministry of Health for bone marrow donor recruitment, HLA typing, registry management, and stem cell collection coordination. Over 1.2 million donor candidates are registered.

3T.C. Milli Eğitim Bakanlığı (Ministry of National Education)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2006-08-08
Description

Nationwide voluntary blood donor education and recruitment program in schools. Since 2006, 890,292 units of blood collected through 20,632 school-based teams. The Okulumda Kanpanya Var project extends this to kindergarten through secondary school levels.

kanver.org
4Talasemi Federasyonu ve Kan Hastalıkları Federasyonu
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for the Biz İyilik Severiz (BİS) project targeting thalassemia and sickle cell anemia patients. Creates a dedicated donor pool of 40,783 people and 4,063 regular donors for matched blood transfusions to reduce alloimmunization.

kanver.org
5TİKA (Türk İşbirliği ve Koordinasyon Ajansı Başkanlığı)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

International cooperation through which Türk Kızılay shared its blood donation expertise with Bosnia and Herzegovina. Training program for 24 healthcare workers from 10 cities on donor recruitment strategies and field applications.

kanver.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Annual blood donation campaign in Gaziantep's Şahinbey district, now in its 17th year. 65,880 units of blood collected over 17 years. Municipality provides organizational support and promotional gifts for donors.

7Various Municipalities and Public Institutions
Strategic tierMinorTypeStrategic or Co-development Partner
Description

82 institutional partnerships with corporations, municipalities, and government bodies for organized blood donation campaigns, venue provision, and promotional support.

kanver.org
Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Statutory UK authority for blood, organs, and stem cell supply with nationwide collection infrastructure and integrated donor registries; directly comparable to Kızılay's mandated national role and full-service blood and cellular therapy coordination.

TypeDirect peer
Description

Operates the largest global hematopoietic stem cell donor registry and coordinates bone marrow transplants; directly comparable to TÜRKÖK in registry-based stem cell donor recruitment, HLA typing, and patient-donor matching.

TypeDirect peer
Description

Italy's national authority coordinating regional blood services and transfusion medicine under the Ministry of Health; directly comparable as a national coordinator of blood collection, quality standards, and stem cell registries.

TypeDirect peer
Description

France's national, publicly-operated blood service with mandated monopoly on blood collection; directly comparable in regulated national monopoly structure, plasma-derived medicine coordination with LFB, and full geographic coverage.

TypeDirect peer
Description

Operates the largest U.S. blood collection and distribution network under the American Red Crescent equivalent nonprofit structure; directly comparable as a Red Cross/Red Crescent national blood service with voluntary donor mobilization, regional centers, and stem cell services.

TypeDirect peer
Description

Australian Red Cross-affiliated national blood service operating collection centers across Australia; directly comparable as a Red Cross national blood operator with voluntary donor model and integrated apheresis and stem cell services.

TypeDirect peer
Description

Canada's national, non-profit blood operator funded by provincial governments; directly comparable in mandate (national blood supply authority), regional center structure, and stem cell registry (OneMatch, merged into CBS).

8Hellenic National Blood Center (EKEA)
TypeRegional player
Description

Greek national blood service operating under similar public-mandate model; comparable as a regional Southern European national blood service with voluntary donor mobilization and hospital distribution.

TypeDirect peer
Description

Largest blood collection organization in Germany under the German Red Cross umbrella; directly comparable as a Red Cross national blood service operating regional centers, voluntary donor model, and plasma-derived therapy partnerships.

TypeBroad incumbent
Description

World's largest plasma collection network and parent of CSL Behring, a global plasma-derived therapeutics manufacturer; comparable as a major incumbent in plasma collection and fractionation that Kızılay's Protürk facility is positioned to compete with domestically.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü

Blood Banking Serviceskanver.org

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the Turkish Red Crescent's national blood services directorate, operating 18 regional blood centers and 68 donation centers across all 81 provinces of Turkey to collect, test, and distribute blood, apheresis, plasma, and stem cell donations free of charge to hospitals and patients under Law No. 5624.

What Türk Kızılay Kan Hizmetleri Genel Müdürlüğü does

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the General Directorate of Blood Services of the Turkish Red Crescent (Türkiye Kızılay Derneği), a public-benefit humanitarian association established as a separate directorate in 1983 with blood service roots dating to 1921. It is the legally designated national blood supply authority of Turkey under Law No. 5624, operating 18 Regional Blood Centers, 68 Blood Donation Centers, and approximately 300 daily mobile collection points covering all 81 provinces. In 2025, the organization collected 3,041,278 units of blood, the highest annual figure in its history, with 1,246,400 additional units in the first five months of 2026. The technical backbone is a blood-banking automation system implemented in 2006, an integrated quality management system certified to ISO 9001:2015 and ISO 10002:2018, and nucleic acid amplification testing (NAT) added October 30, 2014 for HIV, Hepatitis B, Hepatitis C, and Syphilis screening.

Core service lines include voluntary whole-blood donation, apheresis (platelet) donation, plasma donation, and stem cell coordination through TÜRKÖK, a national registry jointly operated with the Ministry of Health since November 7, 2013, which holds 1,231,392 active donor candidates and has completed 8,500 stem cell collections. Supporting assets include the iOS/Android Türk Kızılay Mobil Kan Bağışı application, the kanver.org appointment platform, university (Hedef 25), school (Okulumda Kanpanya Var), youth (Genç Kızılay Kan Elçileri), and mukhtar-led neighborhood (Mahallenin Gücü) donor acquisition programs, the Blood Donation League sports-fan campaign, and a thalassemia/sickle-cell patient-donor matching project (BİS).

Blood and blood components are provided free of charge to hospitals and patients as a public service; no revenue is generated from blood product distribution. Operations are funded through government support, donations, and the parent Türk Kızılay's humanitarian funding base, with no external investors or venture capital involved. Forward strategy centers on the Protürk Plasma Drug Facility, a joint venture with South Korea's SK Plasma in Çubuk, Ankara (groundbreaking June 2026), intended to manufacture albumin, immunoglobulin, and clotting factors domestically and reduce an estimated €450 million in annual plasma-derived medicine imports.

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü firmographics

Firmographics
Name
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
Legal name
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
Website
https://kanver.org
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
51–100 employees
Short description
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the Turkish Red Crescent's national blood services directorate, operating 18 regional blood centers and 68 donation centers across all 81 provinces of Turkey to collect, test, and distribute blood, apheresis, plasma, and stem cell donations free of charge to hospitals and patients under Law No. 5624.
Ownership category
akta.pro rank

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü industry classification

Industry
Product category
Blood Banking Services
NAICS
Blood and Organ Banks (621991)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
akta.pro secondary industries
Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH), Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI)

Keywords

  • Blood banking services
  • Voluntary blood donation
  • Stem cell donation
  • Apheresis services
  • Plasma collection

Where Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is headquartered

Location

Headquarters

HQ city
Ankara
HQ country
Türkiye
HQ region
Europe

Offices3 records

Markets served

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

  1. Blood and Blood Products (Public Service — No Revenue): Türk Kızılay provides blood and blood components free of charge to patients. No fee is charged to patients or their relatives for blood component therapy. This is a public service mandate under Law No. 5624 and does not generate revenue.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü product offering

Product offering

Core offering

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the national blood services authority of Turkey, operating 18 Regional Blood Centers and 68 Blood Donation Centers to collect, test, process, store, and distribute whole blood, erythrocytes, platelets, and plasma free of charge to hospitals. It also coordinates the national hematopoietic stem cell donor registry (TÜRKÖK) with over 1.2 million registered donors for bone marrow transplantation, and is establishing domestic plasma-derived pharmaceutical production through the Protürk facility.

Product overview

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü operates as Turkey's national blood services authority, managing a comprehensive blood supply system through its network of 18 Regional Blood Centers and 68 Blood Collection Facilities. The organization's product portfolio centers on four core service areas: blood donation (including appointments at collection points and mobile units), apheresis services for platelet collection, stem cell donation coordination through the TÜRKÖK national registry, and plasma services. Supporting these core operations are digital platforms including the online blood donation appointment system, the mobile application for iOS/Android, the Blood Donation League gamification initiative, and targeted programs like the 'Biz İyilik Severiz' thalassemia patient-donor matching project. The organization also coordinates international cooperation through its role in the World Bone Marrow Registry and manages educational initiatives including the Hedef 25 university awareness program.

Differentiator

Problem solved

Functional benefit

Brands

  • TÜRKÖK: Türkiye Kök Hücre Koordinasyon Merkezi – Turkey Stem Cell Coordination Center. A joint initiative with the Ministry of Health for hematopoietic stem cell donor recruitment, HLA registry, and bone marrow bank database.
  • Türk Kızılay Mobil Kan Bağışı
  • Genç Kızılay Kan Elçileri (Young Red Crescent Blood Ambassadors)
  • Okulumda Kanpanya Var
  • Biz İyilik Severiz (BİS)
  • Mahallenin Gücü Kan Bağışıyla Büyür
  • Protürk Plazma İlaç Tesisi

Products and services

  • Kan Bağışı (Whole Blood Donation Service) Voluntary whole blood collection from donors at regional centers, donation points, and mobile collection teams; blood is tested (including NAT screening for HIV, Hepatitis B, Hepatitis C, Syphilis), processed into erythrocyte, platelet, and plasma components, and supplied free of charge to hospitals and transfusion centers for patient treatment.
  • Aferez Bağışı (Apheresis Donation Service) Apheresis procedure that separates and collects specific blood components (primarily platelets) from donors while returning other components to the donor. Performed at regional blood centers to support patients requiring targeted platelet transfusions.
  • Plazma Bağışı (Plasma Donation Service) Plasma collection from donors for domestic manufacturing of plasma-derived pharmaceuticals (Albumin, Immunoglobulin, clotting factors) through the Protürk Plasma Drug Facility, reducing Turkey's annual import dependency by approximately €450 million.
  • TÜRKÖK Stem Cell Donor Coordination Service National hematopoietic stem cell donor registry and matching service operated jointly with the Ministry of Health; recruits volunteer donors, performs HLA tissue typing, maintains a database of over 1.2 million donor candidates, and has completed 36,905 patient-donor matchings and 8,500 stem cell collections since inception.
  • Türk Kızılay Mobil Kan Bağışı Uygulaması (Mobile Blood Donation App) Mobile application available on iOS and Android for donor registration, appointment booking at blood donation points, blood type card access, and SMS notifications when donated blood is used by a patient.

Quantifiable outcome

  • 3,041,278 units of blood collected in 2025 — highest annual figure in the organization's history
  • +7 more outcomes

Companies that use Türk Kızılay Kan Hizmetleri Genel Müdürlüğü

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, major and minor.

  • SK Plasma (Güney Koreli)coreStrategic or Co-development Partner · 15 June 2026Türk Kızılay and South Korean SK Plasma are collaborating to build the Protürk Plasma Drug Facility in Çubuk, Ankara. The facility will produce plasma-derived medicines (Albumin, Immunoglobulin, Clotting Factors) domestically, reducing Turkey's import dependency by approximately €450 million annually and creating ~300 jobs.
  • T.C. Sağlık Bakanlığı (Ministry of Health)coreStrategic or Co-development Partner · 7 November 2013TÜRKÖK (Türkiye Kök Hücre Koordinasyon Merkezi) is a joint initiative between Türk Kızılay and the Ministry of Health for bone marrow donor recruitment, HLA typing, registry management, and stem cell collection coordination. Over 1.2 million donor candidates are registered.
  • T.C. Milli Eğitim Bakanlığı (Ministry of National Education)majorStrategic or Co-development Partner · 8 August 2006Nationwide voluntary blood donor education and recruitment program in schools. Since 2006, 890,292 units of blood collected through 20,632 school-based teams. The Okulumda Kanpanya Var project extends this to kindergarten through secondary school levels.
  • Talasemi Federasyonu ve Kan Hastalıkları FederasyonuminorStrategic or Co-development PartnerPartnership for the Biz İyilik Severiz (BİS) project targeting thalassemia and sickle cell anemia patients. Creates a dedicated donor pool of 40,783 people and 4,063 regular donors for matched blood transfusions to reduce alloimmunization.
  • TİKA (Türk İşbirliği ve Koordinasyon Ajansı Başkanlığı)minorStrategic or Co-development PartnerInternational cooperation through which Türk Kızılay shared its blood donation expertise with Bosnia and Herzegovina. Training program for 24 healthcare workers from 10 cities on donor recruitment strategies and field applications.
  • Şahinbey BelediyesiminorStrategic or Co-development PartnerAnnual blood donation campaign in Gaziantep's Şahinbey district, now in its 17th year. 65,880 units of blood collected over 17 years. Municipality provides organizational support and promotional gifts for donors.
  • Various Municipalities and Public InstitutionsminorStrategic or Co-development Partner82 institutional partnerships with corporations, municipalities, and government bodies for organized blood donation campaigns, venue provision, and promotional support.

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü competitors and assessment

Company assessment

Direct peers

  • NHS Blood and Transplant (NHSBT): Statutory UK authority for blood, organs, and stem cell supply with nationwide collection infrastructure and integrated donor registries; directly comparable to Kızılay's mandated national role and full-service blood and cellular therapy coordination.
  • Be The Match (National Marrow Donor Program): Operates the largest global hematopoietic stem cell donor registry and coordinates bone marrow transplants; directly comparable to TÜRKÖK in registry-based stem cell donor recruitment, HLA typing, and patient-donor matching.
  • Italian National Blood Center (CNS / Centro Nazionale Sangue): Italy's national authority coordinating regional blood services and transfusion medicine under the Ministry of Health; directly comparable as a national coordinator of blood collection, quality standards, and stem cell registries.
  • Établissement Français du Sang (EFS): France's national, publicly-operated blood service with mandated monopoly on blood collection; directly comparable in regulated national monopoly structure, plasma-derived medicine coordination with LFB, and full geographic coverage.
  • American Red Cross Biomedical Services: Operates the largest U.S. blood collection and distribution network under the American Red Crescent equivalent nonprofit structure; directly comparable as a Red Cross/Red Crescent national blood service with voluntary donor mobilization, regional centers, and stem cell services.
  • Australian Red Cross Lifeblood: Australian Red Cross-affiliated national blood service operating collection centers across Australia; directly comparable as a Red Cross national blood operator with voluntary donor model and integrated apheresis and stem cell services.
  • Canadian Blood Services: Canada's national, non-profit blood operator funded by provincial governments; directly comparable in mandate (national blood supply authority), regional center structure, and stem cell registry (OneMatch, merged into CBS).
  • German Red Cross Blood Donor Service: Largest blood collection organization in Germany under the German Red Cross umbrella; directly comparable as a Red Cross national blood service operating regional centers, voluntary donor model, and plasma-derived therapy partnerships.

Regional players

  • Hellenic National Blood Center (EKEA): Greek national blood service operating under similar public-mandate model; comparable as a regional Southern European national blood service with voluntary donor mobilization and hospital distribution.

Broad incumbents

  • CSL Plasma: World's largest plasma collection network and parent of CSL Behring, a global plasma-derived therapeutics manufacturer; comparable as a major incumbent in plasma collection and fractionation that Kızılay's Protürk facility is positioned to compete with domestically.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü social profiles

Digital presence

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü compliance and trust

Trust signal

Compliance3 records

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü leadership team

Management profile

Number of profiles

Profiles2 records

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Türk Kızılay Kan Hizmetleri Genel Müdürlüğü

What does Türk Kızılay Kan Hizmetleri Genel Müdürlüğü do?

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the national blood services authority of Turkey, operating 18 Regional Blood Centers and 68 Blood Donation Centers to collect, test, process, store, and distribute whole blood, erythrocytes, platelets, and plasma free of charge to hospitals. It also coordinates the national hematopoietic stem cell donor registry (TÜRKÖK) with over 1.2 million registered donors for bone marrow transplantation, and is establishing domestic plasma-derived pharmaceutical production through the Protürk facility.

Is Türk Kızılay Kan Hizmetleri Genel Müdürlüğü a public or private company?

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Türk Kızılay Kan Hizmetleri Genel Müdürlüğü founded?

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü was founded in 1983. It employs 51 to 100 people.

Where is Türk Kızılay Kan Hizmetleri Genel Müdürlüğü based?

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is headquartered in Ankara, Türkiye, in the Europe region.

How does Türk Kızılay Kan Hizmetleri Genel Müdürlüğü make money?

One revenue line is on record: blood and Blood Products (Public Service — No Revenue).

Who are Türk Kızılay Kan Hizmetleri Genel Müdürlüğü's main competitors?

Direct peers on record are NHS Blood and Transplant (NHSBT), Be The Match (National Marrow Donor Program), Italian National Blood Center (CNS / Centro Nazionale Sangue), Établissement Français du Sang (EFS), American Red Cross Biomedical Services, Australian Red Cross Lifeblood, Canadian Blood Services and German Red Cross Blood Donor Service. Hellenic National Blood Center (EKEA) is listed as a regional player. CSL Plasma is listed as a broad incumbent.

Does Türk Kızılay Kan Hizmetleri Genel Müdürlüğü have an API?

No public API is recorded for Türk Kızılay Kan Hizmetleri Genel Müdürlüğü.

What industry is Türk Kızılay Kan Hizmetleri Genel Müdürlüğü in?

Türk Kızılay Kan Hizmetleri Genel Müdürlüğü's product category is Blood Banking Services. Its primary akta.pro industry code is BPAGACAJ, Blood, Organ & Tissue Donation Organizations, with a secondary code of HLAHAAAH, Blood Bank, Transfusion Medicine & Immunohematology. Its NAICS code is 621991 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales